Industry Challenge
The biopharmaceuticals market is expected to reach US$300 billion by 2025. Innovative therapeutic modalities and biosimilars for blockbuster biologics coming off patent protection are fueling its growth and are pushing manufacturers of biopharmaceuticals to increase process productivity and efficiencies, implement tighter process controls, and reduce costs.
Process development (PD) teams are at the center of these pressures: they are tasked with developing, evaluating, and implementing new technologies to rapidly develop processes for therapeutic assets with limited resources. PD engineers will often turn to new technologies (e.g., sensors) to support their needs, but run into significant challenges when faced with understanding how to implement such new technologies within their own environments to suit their unique objectives.
Client Situation
The mission of Biolympix is to help people tap into the knowledge base of leaders and experts in the biomanufacturing industry. We have an industry leading curated list of experts in upstream and downstream biomanufacturing in applications such as monoclonal antibodies (mAbs), gene therapy, and cell therapy.
Solution
To help the client build an implementation plan, Biolympix identified an industry expert who had practical experience with the sensor and connected the expert with the client. The Biolympix approach centered on:
- The right expert everytime: Biolympix focuses on biomanufacturing so ONLY recruits experts in biomanufacturing. Biolympix identified and vetted experts who have practical experience with Raman spectroscopy the Raman spectrometer, presented their profiles to the client for review, and set up a phone consultation.
- Speed: Biolympix recruited, vetted and set up the phone consultation with the expert within two weeks.